Similarly, the lysosomes of pancreatic ductal adenocarcinoma (PDAC) cells with mutant KRAS show a >0.5 pH unit decrease compared to normal human pancreatic duct epithelial cells or PDAC cells lacking oncogenic KRAS. This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.